Transjugular Intrahepatic Portosystemic Shunt: Indications, Contraindications, and Patient Work-Up
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2014/08/20
-
Indian UGC (journal)
-
Citations70
-
Baljendra Kapoor Imaging Institute, Cleveland Clinic, Cleveland, Ohio
-
Mark Sands Imaging Institute, Cleveland Clinic, Cleveland, Ohio
-
Alexander Copelan Diagnostic Radiology Department, William Beaumont Hospital, Royal Oak, Michigan
Cite
Kapoor, Baljendra, et al. “Transjugular Intrahepatic Portosystemic Shunt: Indications, Contraindications, and Patient Work-Up”. Seminars in Interventional Radiology, vol. 31, no. 03, 2014, pp. 235-42, https://doi.org/10.1055/s-0034-1382790.
Kapoor, B., Sands, M., & Copelan, A. (2014). Transjugular Intrahepatic Portosystemic Shunt: Indications, Contraindications, and Patient Work-Up. Seminars in Interventional Radiology, 31(03), 235-242. https://doi.org/10.1055/s-0034-1382790
Kapoor, Baljendra, Mark Sands, and Alexander Copelan. “Transjugular Intrahepatic Portosystemic Shunt: Indications, Contraindications, and Patient Work-Up”. Seminars in Interventional Radiology 31, no. 03 (2014): 235-42. https://doi.org/10.1055/s-0034-1382790.
Kapoor B, Sands M, Copelan A. Transjugular Intrahepatic Portosystemic Shunt: Indications, Contraindications, and Patient Work-Up. Seminars in Interventional Radiology. 2014;31(03):235-42.
Journal Categories
Medicine
Medicine (General)
Medicine
Medicine (General)
Medical physics
Medical radiology
Nuclear medicine
You May Also Like
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies
- Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System
- Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice Committee
- Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Disparity Among African Americans in Transjugular Intrahepatic Portosystemic Shunt Procedure: A National Inpatient Sample Analysis from 2015 to 2020 | Digestive Diseases and Sciences |
| 2024 | |
| Treatment of Gastric Varices | Current Hepatology Reports | 2024 | ||
| The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure: A national inpatient sample analysis from 2015 to 2020 | Clinics and Research in Hepatology and Gastroenterology |
| 2024 | |
| Safety and efficacy of transjugular intrahepatic portosystemic shunts vs endoscopic band ligation plus propranolol in patients with cirrhosis with portal vein thrombosis: a systematic review and meta-analysis | Journal of Gastrointestinal Surgery |
| 2024 | |
Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy | Journal of Clinical Interventional Radiology ISVIR |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 42
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Transjugular intrahepatic portosystemic shunt using transsplenic access with balloon-assisted puncture technique in a patient with chronic and complete occlusion of portal vein and was published in 2015. The most recent citation comes from a 2024 study titled The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure: A national inpatient sample analysis from 2015 to 2020. This article reached its peak citation in 2021, with 14 citations. It has been cited in 59 different journals, 23% of which are open access. Among related journals, the European Journal of Gastroenterology & Hepatology cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.